#MedTech #Ireland #Waterford #Schivo #Mecaplast

Schivo Expands Precision Manufacturing with Mecaplast Acquisition

In a significant strategic move, Schivo has announced the acquisition of Mecaplast SA, a highly specialized Swiss manufacturer known for its high-precision injection-molded components tailored for the medical device and life sciences sectors. The acquisition, which took place on September 3, 2025, marks a pivotal moment for Schivo as they aim to broaden their expertise in advanced manufacturing processes.

Founded in 1971 and headquartered in Botterens, Switzerland, Mecaplast has established a stellar reputation for technical excellence. With a strong emphasis on producing mission-critical components, the company has been at the forefront of precision mold creation and cleanroom assemblies for leading MedTech and life sciences OEMs (Original Equipment Manufacturers). Their ISO 13485-certified facility, encompassing over 64,000 square feet of dedicated production space, specializes in an array of manufacturing techniques, including micro-molding, over-molding, and injection molding, coupled with automation processes.

Elevating Production Capabilities

By acquiring Mecaplast, Schivo enhances its vertical integration capabilities, now including extensive experience in plastics, metals, and ceramics manufacturing, along with assembly and value-added services. This acquisition is set to fortify Schivo's operations in the U.S. and Mexico, as a new European center of excellence will be established, focused on advanced injection molding capabilities—a vital element for boosting support for MedTech and life sciences OEMs across international markets.

Graham Reeves, the CEO of Schivo, expressed his enthusiasm for the acquisition, stating, "Mecaplast brings decades of deep expertise in complex plastics, metals, and ceramics, perfectly aligning with our vision of creating a global, multi-capability platform for advanced medical and life sciences devices serving robotic surgical, minimally invasive surgical, and analytical instrumentation segments." This alignment not only enhances Schivo's technological prowess but also strengthens their commitment to innovation in the field.

Commitment to Innovation and Expansion

Jean-Marc Jaccottet, the CEO and owner of Mecaplast, echoed these sentiments, stating, "Joining Schivo represents a natural and exciting evolution for Mecaplast SA. Our team looks forward to serving our long-standing customers while also meeting the needs of new clients. This partnership accelerates investments and development, leveraging the combined expertise of both companies to expand the impact of our Swiss-based skills in precision injection molding and cutting-edge manufacturing."

The Mecaplast facility will serve as Schivo's Global Center of Excellence for molding and precision plastics, further establishing the company as a leader in the advanced molding solutions sector. Jean-Marc Jaccottet will be joining Schivo's leadership team as President of Molding Technologies, where he will be responsible for leading research and development, innovation initiatives, and driving the group’s capacity growth.

About Schivo

Schivo is at the forefront of creating the medical and life science devices of the future by partnering with industry leaders and innovators. They help develop, manufacture, assemble, and deliver prototypes and finished devices, facilitating the market introduction of cutting-edge technologies in the medical device, life sciences, and analytical markets. By serving as an extension of their clients' development teams, Schivo addresses unique engineering challenges and creates innovative manufacturing processes that simplify the supply chain, supporting clients from concept to commercial launch.

For further details, visit www.schivomedical.com to learn more about their expansive capabilities and how they are shaping the future of MedTech and life sciences.